Overestimation of Hereditary Breast Cancer Risk
- 1 September 1998
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 228 (3) , 375-384
- https://doi.org/10.1097/00000658-199809000-00010
Abstract
To find out how women with breast or ovarian cancer rate their chances of carrying hereditary factors for these cancers and to determine the extent to which they overestimate their risk. BRCA1 and BRCA2 are genes that cause breast and ovarian cancer when they are inherited in families. Testing for disease-associated mutations in these genes is now available commercially. Previous studies have shown that women overestimate their chances of carrying mutations. However, women's perceptions of risk have not been compared to objective estimates or to actual BRCA1 and BRCA2 testing results. This study examines estimates of carrying BRCA1 and BRCA2 mutations among women participating in a randomized trial comparing alternative precounseling educational materials. Estimates were provided by participants in a baseline mailed survey. Estimates given by participants were compared to those given by an expert panel and by a statistical model. Testing was offered free of charge and was done in an academic laboratory using standard techniques. Baseline estimates of participating women were compared to the estimates of the expert panel, to the carrier probability provided by the statistical model, and to actual testing results. Women who have a personal history of breast or ovarian cancer significantly overestimate their risk of carrying hereditary factors for breast and ovarian cancer. Self-estimates exceeded the estimates of experts and a statistical model. One hundred women completed testing, and 21 mutations in BRCA1 or BRCA2 were found. Many test-negative women also overestimated their hereditary risk. Some women with a high carrier probability were negative for BRCA1 and BRCA2 mutations. Overestimation of hereditary factors is common among affected women with a family history of cancer. Pretest education and counseling should reduce these high-risk perceptions. Better estimates of carrier probability will direct more intensive clinical services and research.Keywords
This publication has 29 references indexed in Scilit:
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family HistoryJNCI Journal of the National Cancer Institute, 1997
- Coming to Grips With Genes and RiskScience, 1996
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer familiesNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Interest in genetic testing among first‐degree relatives of breast cancer patientsAmerican Journal of Medical Genetics, 1995
- Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome ResearchPublished by American Medical Association (AMA) ,1994
- Physiciansʼ knowledge of genetics and genetic testsAcademic Medicine, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990